Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-04-08

FDA Approved: AZELASTINE HYDROCHLORIDE AND FLUTICASONE PROPIONATE — Original Application (Teva Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved the original application for a fixed-dose combination nasal spray of azelastine hydrochloride and fluticasone propionate by Teva, indicated for all…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • AZELASTINE HYDROCHLORIDE AND FLUTICASONE PROPIONATE (AZELASTINE HYDROCHLORIDE AND FLUTICASONE PROPIONATE)

Snippet

ORIG AP for AZELASTINE HYDROCHLORIDE AND FLUTICASONE PROPIONATE (AZELASTINE HYDROCHLORIDE AND FLUTICASONE PROPIONATE)